Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

Arthritis (juvenile idiopathic, systemic) - tocilizumab: review decision April 2015 information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - GE decision paper - March 2015

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - GE decision paper - March 2015 (PDF 107 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: review proposal information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix A - matrix of stakeholders (PDF 100 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appendix B - GE proposal paper January 2015

Arthritis (juvenile idiopathic, systemic) - tocilizumab: equality impact assessment

Arthritis (juvenile idiopathic, systemic) - tocilizumab: final appraisal determination information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: final appraisal determination

Arthritis (juvenile idiopathic, systemic) - tocilizumab: final appraisal determination (PDF 254 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: response to consultee, commentator and public comments on the appraisal consultation document (ACD)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: response to consultee, commentator and public comments on the appraisal consultation document (ACD) (PDF 262 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: consultee and commentator comments on the ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD (PDF 745 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PAS template

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PAS template (PDF 238 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PSA

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - PSA (PDF 195 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - additional analysis as requested by ERG

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - additional analysis as requested by ERG (PDF 160 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS (PDF 230 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: NRAS comments on ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: NRAS comments on ACD (PDF 357 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: BSPAR comments on ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: BSPAR comments on ACD (PDF 122 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Abbott comments on ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Abbott comments on ACD (PDF 70 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: ARUK comments on ACD

Arthritis (juvenile idiopathic, systemic) - tocilizumab: ARUK comments on ACD (PDF 292 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: comments on the ACD from Dr Jeremy Camilleri (nominated by the Welsh Government)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: comments on the ACD from Dr Jeremy Camilleri (nominated by the Welsh Government) (PDF 6.7 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: additional ERG critique post ACD by Kleijnen Systematic Reviews

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation document information

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - evaluation report

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - pre-meeting briefing

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - pre-meeting briefing (PDF 332 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report (PDF 1019 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - ERG report Errata

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - ERG report Errata (PDF 148 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report (factual accuracy check)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - Evidence Review Group report (factual accuracy check) (PDF 248 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - manufacturer submission

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - manufacturer submission from Roche

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - manufacturer submission from Roche (PDF 2.66 MB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification letter

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification letter (PDF 131 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification response

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - clarification response (PDF 570 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - patient group, professional group and NHS organisation submission statements

Arthritis Care

Arthritis Care (PDF 60 KB)

British Health Professionals in Rheumatology

British Health Professionals in Rheumatology (PDF 72 KB)

British Society for Paediatric and Adolescent Rheumatology

British Society for Paediatric and Adolescent Rheumatology (PDF 90 KB)

National Rheumatoid Arthritis Society

National Rheumatoid Arthritis Society (PDF 951 KB)

Royal College of Pathologists

Royal College of Pathologists (PDF 69 KB)

Arthritis (juvenile idiopathic, systemic) - tocilizumab: appraisal consultation - expert written personal statements

Camilleri

Camilleri (PDF 179 KB)

Copeland

Copeland (PDF 62 KB)

Gebbie

Gebbie (PDF 156 KB)

Wood

Arthritis (juvenile idiopathic) - tocilizumab; final scope

Arthritis (juvenile idiopathic) - tocilizumab; final matrix

Arthritis (juvenile idiopathic) - tocilizumab: scoping equality impact assessment 

Arthritis (juvenile idiopathic) - tocilizumab; draft scope

Arthritis (juvenile idiopathic) - tocilizumab; provisional matrix